Back to Search
Start Over
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
- Source :
- Kidney International, Kidney International, Nature Publishing Group, 2019, 95 (2), pp.281-295. ⟨10.1016/j.kint.2018.11.008⟩, Kidney International, 95, 2, pp. 281-295, Kidney International, 95, 281-295
- Publication Year :
- 2019
-
Abstract
- Contains fulltext : 203024.pdf (Publisher’s version ) (Open Access) In November 2017, the Kidney Disease: Improving Global Outcomes (KDIGO) initiative brought a diverse panel of experts in glomerular diseases together to discuss the 2012 KDIGO glomerulonephritis guideline in the context of new developments and insights that had occurred over the years since its publication. During this KDIGO Controversies Conference on Glomerular Diseases, the group examined data on disease pathogenesis, biomarkers, and treatments to identify areas of consensus and areas of controversy. This report summarizes the discussions on primary podocytopathies, lupus nephritis, anti-neutrophil cytoplasmic antibody-associated nephritis, complement-mediated kidney diseases, and monoclonal gammopathies of renal significance.
- Subjects :
- 0301 basic medicine
Nephrology
medicine.medical_specialty
membranoproliferative glomerulonephritis
Consensus Development Conferences as Topic
030232 urology & nephrology
Lupus nephritis
Paraproteinemias
Context (language use)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
anti-neutrophil cytoplasmic antibody–associated vasculitis
03 medical and health sciences
0302 clinical medicine
Glomerulonephritis
Risk Factors
[SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]
Internal medicine
Membranoproliferative glomerulonephritis
medicine
Humans
Minimal change disease
C3 glomerulopathy
Genetic Testing
Intensive care medicine
ComputingMilieux_MISCELLANEOUS
KDIGO
lupus nephritis
business.industry
Podocytes
Nephrosis, Lipoid
monoclonal gammopathies of renal significance
Guideline
medicine.disease
focal and segmental glomerulosclerosis
3. Good health
minimal change disease
030104 developmental biology
Treatment Outcome
Practice Guidelines as Topic
Disease Progression
Renal disorders Radboud Institute for Health Sciences [Radboudumc 11]
business
Biomarkers
Kidney disease
Glomerular Filtration Rate
Subjects
Details
- ISSN :
- 00852538 and 15231755
- Volume :
- 95
- Database :
- OpenAIRE
- Journal :
- Kidney International
- Accession number :
- edsair.doi.dedup.....28f618b1b8a74228935389cbb06c39a0
- Full Text :
- https://doi.org/10.1016/j.kint.2018.11.008